| P2093 | author name string | Ashley D | |
| | Bicknell W | |
| | Harik V | |
| | Trisolini M | |
| P2860 | cites work | New issues in therapy after renal transplantation | Q93872264 |
| | Reforming the health sector in developing countries: the central role of policy analysis | Q33556632 |
| | Ten Tanzanian transplants: problems and perspectives | Q36722589 |
| | As children survive: dilemmas of aging in the developing world | Q38612386 |
| | Nephrology and the rationing of health care | Q40867060 |
| | Latin American nephrology: present state and future concerns. Committee on Nephrology Development and National Problems of the Latin American Society of Nephrology and Hypertension (SLANH). | Q40882868 |
| | The Oregon experiment: the role of cost-benefit analysis in the allocation of Medicaid funds | Q40886677 |
| | Current strategies for retarding progression of renal disease | Q41681046 |
| | Renal replacement therapy in Singapore. | Q43572085 |
| | Does epidemiological transition have utility for health planners? | Q47232142 |
| | Kidney failure and transplantation in China | Q47793737 |
| | Registration of births, stillbirths and infant deaths in Jamaica. | Q53366170 |
| | What transplantation can teach us about health care reform. The Ethics and Social Impact Committee | Q58680889 |
| | Cost-effectiveness analysis of the treatment of end-stage renal disease in Brazil | Q67301696 |
| | End-stage renal disease in Latin America: socioeconomic aspects of its therapy | Q69779572 |
| | The organization of medical care. Lessons from the Medicare end stage renal disease program | Q70513368 |
| | The American health care system. The End Stage Renal Disease Program | Q70528646 |
| | The Oregon priority-setting exercise: cost-effectiveness and the rule of rescue, revisited | Q71459803 |
| | HLA matching in renal transplantation | Q72139412 |
| | Renal transplantation | Q72442105 |
| | The diabetes control and complications trial. Implications for policy and practice | Q72914726 |
| | Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group | Q73632528 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 16 | |
| P304 | page(s) | 905-920 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Social Science and Medicine | Q7550785 |
| P1476 | title | Policy analysis for end-stage renal disease in Jamaica | |
| P478 | volume | 49 | |